1.3 Therapeutical Schemes on Graves Ophthalmopathy:Cost-effectiveness Analysis
China Pharmacy 1991;0(01):-
OBJECTIVE:To Study the cost-effectiveness among3therapeutical schemes in the treatment of Graves ophthalmopathy.METHODS:A total of94cases with Graves ophthalmopathy were randomized into3groups,Group A was assigned to receive medrat,Group B to receive dexamethasone and Group C to receive prednisone,the outcomes were evaluated in terms of the cost-effectiveness analysis.RESULTS:The costs for Group A,B and C were2956.76yuan,2059.42yuan and31.09yuan,respectively.The total effective rates were93.94%,93.75%and51.72%,respectively.The cost-effec-tiveness ratios were31.47yuan,21.97yuan and0.60yuan,respectively.The incremental cost-effectiveness ratios of Group A and B were69.30yuan and48.26yuan,respectively as against Group C.CONCLUSION:In terms of pharmacoeconomics,Group B is comparatively the best option in treating Graves ophthalmopathy.
2.Cost-Effectiveness Analysis of 3 Therapeutic Schemes for Parkinson's Disease
China Pharmacy 1991;0(02):-
OBJECTIVE:To evaluate the cost-effectiveness of 3 therapeutic schemes in the treatment of Parkinson's disease (PD). METHODS:A total of 94 PD cases were randomly assigned into 3 groups:Group A (Benserazide tablets +carbidopa and Levodopa controlled release tablets),Group B (Benserazide tablets+Carbidopa and Levodopa controlled release tablets+Selegiline tablets) and Group C (Benserazide tablets+Carbidopa and Levodopa controlled release tablets+Entacapone tablets). After treatment for 8 weeks,the cost-effectiveness analysis were conducted for all the 3 groups. RESULTS:For Group A,B and C,the costs were 448.78,803.89,1 559.89 yuan,respectively; the total effective rates were 56.67%,83.33% and 85.71%,respectively; the cost-effectiveness ratios were 791.92,964.71,1 819.96,respectively. The incremental cost-effectiveness ratios of Group B and C were 1 332.00 and 3 826.14,respectively as against Group A. CONCLUSION:Group B is preferable for PD among the 3 groups.
3.Evaluation of characteristics of cerebral vascular lesion in hypertensive patients by transcranial Doppler
Xiaohong XI ; Yuefen FEN ; Bo XU
Medical Journal of Chinese People's Liberation Army 2001;0(11):-
Objective To investigate the degree of vascular damage in patients with hypertension in various stages with transcranial Doppler (TCD), so as to provide references for the prevention and treatment of obstructive cerebral vascular disease. Methods TCD was adopted to examine bilateral anterior cerebral arteries (ACA), terminal internal carotid arteries (TICA), vertebral arteries (VA) and basal arteries (BA) in patients with hypertension (n=176) and normotensive individuals as control group (n=60). The hemodynamic data of two groups were analyzed statistically. Results In patients with stage Ⅰ hypertension, the blood stream velocity was increased in all intracranial vessels, especially in MCM and TICA. In patients with stage Ⅱ and Ⅲ hypertension, the elevation of blood pressure was followed by the decrease of blood stream velocity, especially in MCA, TICA and BA. The rate of abnormality as detected by TCD was 90 and 96 in patients with stage Ⅱ and Ⅲof hypertension, respectively. Conclusions The abnormal findings of cerebral vessels as detected by TCD seem to coincide with the clinical characters of stroke. TCD findings may be used as an early forewarning index of obstructive cerebral disease.